News and commentary from the psychiatry world ...

It's effective for those whose depression doesn't improve on medication. However, it's not necessarily convenient as this ...

Inside a wellness spa in Chicago’s River North neighborhood, a video of Gwyneth Paltrow plays on a quiet loop near the ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...

It's not a drug, and it may also have some benefits to quell overeating—here's how tech is transforming mental health care.

The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...

The new platform aims to help oversize and over-dimensional carriers price and book higher-margin freight with greater ...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo® Transcranial Magnetic Stimulation (TMS) machines nationwide.

Real-time data insights are transforming logistics performance, driving down costs and improving CO2 emissions management.

WILMINGTON, Del. and MUNICH, Jan. 05, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company and neurocare Group AG today (“The Partners”) ...

One local clinic is pushing for people to consider transcranial magnetic stimulation therapy. The therapy is FDA approved to treat depression and OCD and does not use drugs. Experts say the only side ...